SB 163 South Dakota Senate · 2022 Regular Session

address transparency in prescription drug pricing.

Bill status passed 3 of 5 stages cleared

Introduction

Jan 2022

Committee Review

Feb 2022

Senate Passage

Feb 2022

House Passage

Governor

Introduced Jan 27, 2022 Last action Feb 23, 2022

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

Feb 23, 2022

Upper · Passed

Senate Reconsidered , Passed, YEAS 16, NAYS 19 S.J. 372

upper

Feb 23, 2022

Upper · Passed

Intent to reconsider , Passed, S.J. 341

upper

Feb 23, 2022

Upper · Passed

Senate Do Pass Amended , Passed, YEAS 17, NAYS 17 S.J. 341

upper

Feb 23, 2022

Introduced

Senate Motion to amend , Passed, S.J. 340 Amendment 163D

upper

Feb 22, 2022

Upper · Passed

Senate Deferred to another day , Passed, S.J. 304

upper

Feb 16, 2022

Upper · Passed

Health and Human Services Do Pass Amended , Passed, YEAS 5, NAYS 2

upper

Feb 16, 2022

Introduced

Health and Human Services Motion to amend , Passed, Amendment 163C

upper

Jan 27, 2022

Introduced

First read in Senate and referred to S.J. 129

upper

13 primary · 0 co-sponsors

Sponsors

Role

Legislator

Party

State

District